2017
DOI: 10.1167/tvst.6.2.10
|View full text |Cite
|
Sign up to set email alerts
|

Dramatic Effect of Oral CSF-1R Kinase Inhibitor on Retinal Microglia Revealed by In Vivo Scanning Laser Ophthalmoscopy

Abstract: This report provides sound evidence that the small molecule pharmaceutical PLX5622, a highly selective CSF-1R kinase inhibitor, crosses the blood–retina barrier and suppresses microglia activity. Members of this class of drug are in advanced clinical development stages and may represent a novel approach to modulate ocular inflammatory processes.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

2
14
0

Year Published

2017
2017
2023
2023

Publication Types

Select...
7

Relationship

3
4

Authors

Journals

citations
Cited by 13 publications
(16 citation statements)
references
References 10 publications
2
14
0
Order By: Relevance
“…At D3-7, microglial cell bodies and processes got thicker and showed a bipolar shape associated with an axon. Scale bars: 100 μm and 25 μm in (a) and (b) [Color figure can be viewed at wileyonlinelibrary.com] (Figure 4c), similar to the previous report (Ebneter, Kokona, Jovanovic, & Zinkernagel, 2017). In our condition, PLX did not change the number of RGCs in the absence of NMDA.…”
Section: Pharmacological Ablation Of Microglia Protects Rgcssupporting
confidence: 89%
See 1 more Smart Citation
“…At D3-7, microglial cell bodies and processes got thicker and showed a bipolar shape associated with an axon. Scale bars: 100 μm and 25 μm in (a) and (b) [Color figure can be viewed at wileyonlinelibrary.com] (Figure 4c), similar to the previous report (Ebneter, Kokona, Jovanovic, & Zinkernagel, 2017). In our condition, PLX did not change the number of RGCs in the absence of NMDA.…”
Section: Pharmacological Ablation Of Microglia Protects Rgcssupporting
confidence: 89%
“…and (b) [Color figure can be viewed at wileyonlinelibrary.com] (Figure 4c), similar to the previous report(Ebneter, Kokona, Jovanovic, & Zinkernagel, 2017). In our condition, PLX did not change the number of RGCs in the absence of NMDA.…”
supporting
confidence: 90%
“…To investigate the role of resident microglia on the LPS-induced phenotype, we employed the highly selective CSF-1R inhibitor PLX5622, which has been previously shown to deplete microglia in the CNS [24, 56]. Accumulation of sub-retinal fluid and retinal swelling were completely abrogated by PLX5622 (Fig.…”
Section: Discussionmentioning
confidence: 99%
“…Moreover, a single LPS injection triggered the production of a plethora of inflammatory mediators in the retina and this phenomenon was abolished after repeated injections. In addition, the use of a colony-stimulating factor 1-receptor (CSF1-R) inhibitor, which we have previously shown to dramatically deplete retinal microglia [24], provides evidence that the breakdown of the BRB can be abrogated by suppression of the innate immune response. These data suggest that resident retinal microglia in combination with monocytes invading from the circulation are responsible for the breakdown of the BRB and that BRB integrity can be preserved by inhibition of the CSF-1R.…”
Section: Introductionmentioning
confidence: 99%
“…Using SLO, we could identify gfp positive microglia cells as hyperreflective signal in the auto fluorescent images, however the wide field 102 ° lens was able to cover a larger fundus area compared to the 55 ° lens. SLO can also be utilized for the monitoring of retinal microglia cells distribution and activation in reporter mice with a functional fractalkine receptor (Cx3cr1 gfp/+ mice) in normal or diseased retina 12,21,32 . The combination of SD-OCT with SLO in the same imaging session can provide information about microglia distribution and activation upon retinal degeneration and could be useful for monitoring retinal diseases in mice 21 .…”
Section: Representative Resultsmentioning
confidence: 99%